MULTIPHASE PHARMACEUTICAL PREPARATION FOR OVULATION INHIBITION IN MAMMAL

摘要

FIELD: medicine. ^ SUBSTANCE: multiphase pharmaceutical preparation for ovulation inhibition in mammal contains a number of individually packed and individually removed daily units placed in a single package, and used for oral administration for at least 21 days running; specified daily units contain a combination of oestradiol and drospirenone. A daily unit contains 0.5 to 4 mg of oestradiol and 2 to 4 mg of drospirenone. At least 70% of specified drospirenone are released from specified unit within 30 minutes. ^ EFFECT: invention provides higher oral bioavailability of drospirenone. ^ 6 cl, 5 dwg, 5 ex